Literature DB >> 23059769

Cardiopulmonary variables during exercise predict pregnancy outcome in women with congenital heart disease.

Hideo Ohuchi1, Yuka Tanabe, Chizuko Kamiya, Kanae Noritake, Kenji Yasuda, Aya Miyazaki, Tomoaki Ikeda, Osamu Yamada.   

Abstract

BACKGROUND: Maternal New York Heart Association (NYHA) class is associated with pregnancy outcome in women with congenital heart disease (WCHD), but objective predictive criteria of exercise capacity have not been established. METHODS AND
RESULTS: A total of 33 WCHD (age, 28 ± 5 years; NYHA class, 1.3 ± 0.6) who had undergone cardiopulmonary exercise testing (CPX) 1.8 ± 2.2 years before their delivery were retrospectively identified. Maternal, cardiac, and neonatal events occurred in 8 (24%), 12 (36%), and 14 (42%), respectively. All CPX parameters correlated with neonatal birth weight (P<0.05-0.001). Exercise time, peak heart rate (HR), peak systolic blood pressure, and peak oxygen uptake (VO(2)) were associated with cardiac events (P<0.05-0.01), and exercise time and peak VO(2) were also associated with neonatal events (P<0.05). Exercise time, peak HR, and peak VO(2) were associated with at least 1 of the 3 events (P<0.05-0.01). Receiver operating characteristic analysis showed that peak HR <150 beats/min and/or peak VO(2) <22.0 ml · kg(-1) · min(-1), peak VO(2) <26.2 ml · kg(-1) · min(-1), and peak HR <150 beats/min and/or peak VO(2) <25.3 ml · kg(-1) · min(-1) predicted a high probability of maternal cardiac, neonatal, and maternal cardiac and/or neonatal event, respectively.
CONCLUSIONS: CPX parameters predict pregnancy outcome and peak HR ≥ 150 beats/min and/or peak VO(2) ≥ 25 ml · kg(-1) · min(-1) may be reference value(s) for a safer pregnancy outcome in WCHD.

Entities:  

Mesh:

Year:  2012        PMID: 23059769     DOI: 10.1253/circj.cj-12-0485

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  7 in total

Review 1.  Congenital and Acquired Valvular Heart Disease in Pregnancy.

Authors:  Sarah A Goldstein; Cary C Ward
Journal:  Curr Cardiol Rep       Date:  2017-08-24       Impact factor: 2.931

Review 2.  Pregnancy in adults with congenital heart disease.

Authors:  Elvin Zengin; Götz Mueller; Stefan Blankenberg; Yskert von Kodolitsch; Carsten Rickers; Christoph Sinning
Journal:  Cardiovasc Diagn Ther       Date:  2019-10

3.  Clinical features and peripartum outcomes in pregnant women with cardiac disease: a nationwide retrospective cohort study in Japan.

Authors:  Toshiaki Isogai; Hiroki Matsui; Hiroyuki Tanaka; Akira Kohyama; Kiyohide Fushimi; Hideo Yasunaga
Journal:  Heart Vessels       Date:  2018-02-17       Impact factor: 2.037

Review 4.  Management of Women With Congenital or Inherited Cardiovascular Disease From Pre-Conception Through Pregnancy and Postpartum: JACC Focus Seminar 2/5.

Authors:  Kathryn J Lindley; C Noel Bairey Merz; Anita W Asgar; Natalie A Bello; Sonal Chandra; Melinda B Davis; Mardi Gomberg-Maitland; Martha Gulati; Lisa M Hollier; Eric V Krieger; Ki Park; Candice Silversides; Natasha K Wolfe; Carl J Pepine
Journal:  J Am Coll Cardiol       Date:  2021-04-13       Impact factor: 24.094

Review 5.  Pregnancy complicated by valvular heart disease: an update.

Authors:  Michael Nanna; Kathleen Stergiopoulos
Journal:  J Am Heart Assoc       Date:  2014-06-05       Impact factor: 5.501

Review 6.  Adult Congenital Heart Disease with Pregnancy.

Authors:  Koichiro Niwa
Journal:  Korean Circ J       Date:  2018-04       Impact factor: 3.243

Review 7.  Pregnancy in congenital heart disease: risk prediction and counselling.

Authors:  Iris M van Hagen; Jolien W Roos-Hesselink
Journal:  Heart       Date:  2020-07-01       Impact factor: 5.994

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.